Olivier D. Christophe

Principal Investigator, Director of research
Laboratory for Hemostasis, Inflammation and Thrombosis, Unité Mixte de Recherche S1176, Institut National de la Santé et de la Recherche Médicale, Université Paris-Saclay, Le Kremlin-Bicêtre, France

Presentation(s):

• OC 22.4 - Unique humanized mouse models of von Willebrand disease to implement the need for innovative therapeutic strategies

  Sunday, July 10, 2022
  3:30 PM – 3:45 PM

• OC 43.5 - Domain-specific nanobodies distinguish intact and proteolyzed forms of von Willebrand factor in congenital von Willebrand disease

  Monday, July 11, 2022
  3:45 PM – 4:00 PM

• PB0817 - Emicizumab ameliorates hemostasis in von Willebrand Disease type 3 but not type 2A murine models

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• OC 50.4 - Differences in bleeding profiles and venous clot structures between emicizumab and factor VIII-treated mice

  Tuesday, July 12, 2022
  11:30 AM – 11:45 AM